Peptide Microarray for Bacterial Viral Infection Distinction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods fail to accurately distinguish bacterial infections from viral infections, leading to unnecessary antibiotic use due to lack of precise diagnosis, especially in respiratory tract infections and pediatric sepsis.
Innovation Solution
Development of a peptide microarray and method using immobilized peptides that bind specifically to bacterial or viral antibodies, allowing for the differentiation between bacterial and viral infections by analyzing antibody responses, with two peptides (SEQ ID NO.1 and SEQ ID NO.2) identified to effectively distinguish between the two.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current diagnostic methods are used, then general infection detection is possible, but accurate distinction between bacterial and viral infections cannot be achieved
Solution Approach 1:
The patent segments the diagnostic approach by creating separate peptide arrays with distinct peptide sequences that specifically bind to antibodies against different pathogen types. Instead of using a single complex test, the methodology divides the detection into modular peptide units (e.g., peptides 1-10 in Table 1) that can be independently designed and combined, allowing precise differentiation between bacterial and viral infections while maintaining manageable test complexity.
Solution Approach 2:
The patent applies parameter changes by modifying peptide sequences to optimize their binding specificity to different antibody types. By systematically varying peptide compositions and structures (as shown in the detailed sequence listings), the methodology achieves enhanced discriminatory power between bacterial and viral infections. This includes adjusting peptide length, amino acid composition, and structural conformation to maximize binding affinity for pathogen-specific antibodies.
2Reliability
If antibiotics are used without accurate diagnosis, then treatment coverage is maintained, but antibiotic overuse and resistance develop
Solution Approach 1:
The patent implements preliminary action by performing pathogen identification through peptide array binding assays before initiating antibiotic treatment. The methodology detects and characterizes antibodies against specific pathogen peptides in patient samples, providing definitive diagnostic information that guides appropriate treatment decisions. This preliminary diagnostic step ensures antibiotics are only prescribed when bacterial infections are confirmed, preventing unnecessary antibiotic use and reducing resistance development.
3Loss of information
If genome-wide expression analysis is used, then comprehensive infection profiling is possible, but the complexity of analysis increases significantly
Solution Approach 1:
The patent extracts only the most relevant diagnostic information by focusing on specific peptide-antibody interactions rather than analyzing entire genomes or transcriptomes. The methodology selects and analyzes binding patterns to a curated set of pathogen-derived peptides, extracting the essential diagnostic signal needed to distinguish bacterial from viral infections. This extraction approach maintains information completeness for diagnostic purposes while dramatically simplifying the analysis compared to comprehensive genome-wide studies.
4Measurement precision
If serological testing with multiple antibodies is performed, then pathogen identification capability improves, but the complexity of the study platform increases
Solution Approach 1:
The patent merges multiple pathogen detection capabilities into a single integrated peptide array platform. Instead of using separate tests for different pathogens, the methodology combines multiple pathogen-specific peptides on one array, allowing simultaneous detection of antibodies against various bacteria and viruses in a single assay. This merging approach maintains high pathogen identification accuracy while reducing the number of separate tests and simplifying the overall diagnostic workflow.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves high specificity and sensitivity in distinguishing bacterial from viral infections, reducing antibiotic overuse by accurately identifying bacterial infections and allowing optimal antibiotic use, with misclassification primarily occurring with influenza viruses.
Implementation Method 1
contacting an antibody-containing sample with an array of immobilized peptides, wherein said peptides are selected from a group consisting of one or more peptides that bind to antibodies produced in response to a bacterial infection
Data Source
AI summary
Assays, arrays, and methods for distinguishing a bacterial infection from a viral infection are disclosed. The antibiotic crisis is in part driven by over prescription of antibiotics. There is a tendency, particular in pediatrics, to give an antibiotic even for viral infections. Thus, embodiments herein are directed to the problem of distinguishing a bacterial infection from a viral infection to reduce unnecessary antibiotic usage.